Search

Your search keyword '"Chi, Dennis S."' showing total 364 results

Search Constraints

Start Over You searched for: Author "Chi, Dennis S." Remove constraint Author: "Chi, Dennis S." Database Unpaywall Remove constraint Database: Unpaywall
364 results on '"Chi, Dennis S."'

Search Results

5. Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State

6. Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes

8. Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations

9. Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series

10. Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer

11. Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study

12. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group

14. A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma

15. Germline drivers of gynecologic carcinosarcomas

16. The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study

18. Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial

19. Supplementary Data from MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

20. Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

21. Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management

22. Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study

23. Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors

24. Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study

25. Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trial

27. Ovarian cancer mutational processes drive site-specific immune evasion

28. Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation

29. List of Contributors

30. Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intrauterine Contraceptive System

31. Risk factors for financial toxicity in patients with gynecologic cancer

34. Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series

35. Gynecologic Survivorship Tool: Development, Implementation, and Symptom Outcomes

36. Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues

37. MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

38. Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes

41. Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer

46. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy

47. Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study

Catalog

Books, media, physical & digital resources